retatrutide fda approval status october 2025 Timeline: Week-by-Week Results (48 Weeks) 🎥 Eli Lilly’s next generation

A second-generation GLP-1 RA (semaglutide) was introduced for oral administration as the world firsts large peptide in a tablet (Aroda et al., 2019)

For patients managing both weight or metabolic health and ulcerative colitis, understanding the intersection of these conditions is essential

Research has demonstrated that individuals with higher body mass indexes (BMI) face increased risk for: Lower-extremity lymphedema Venous disease Phlebolymphedema Delayed wound healing Cellulitis Mobility limitations For this reason, weight management has long been considered an important component of comprehensive lymphedema care

Retatrutide Safety, Side Effects, and Provider-Guided Use Quick Answer Is Retatrutide Safe to Use Without Medical Supervision

Sousa, L

Recent Developments: Initiated Phase 3 trials for orforglipron, aiming to provide an oral alternative to injectable GLP-1 drugs